¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Dehydrocholic Acid and Docusate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • nitrohydrochloric acid
    Áú¿°»ê, ¿Õ¼ö
  • nitrous acid
    ¾ÆÁú»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • orotic acid
    ¿À·ÎÆ®»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • phosphoric acid
    Àλê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • pyruvic acid
    ÇÇ·çºê»ê
  • retinoic acid
    ·¹Æ¼³ë»ê, ·¹Æ¼³ëÀλê
  • ribonucleic acid
    ¸®º¸ÇÙ»ê, ¾Ë¿£¿¡ÀÌ
  • saccharic acid
    »çÄ«¸°»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • saturated acid
    Æ÷È­Áö¹æ»ê
  • sialic fatty acid
    ½Ã¾Ë»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • tannic acid
    ź´Ñ»ê
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • arachidonic acid metabolites
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ÓÛÞóÚªòõ)
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • aromatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê.
  • arormatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê
  • arsenic acid
    ºñ»ê(Ý÷ß«).
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê.
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • free acid
    À¯¸®»ê(ë´ìÆß«).
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • fuming sulfuric acid
    ¹ß¿¬È²»ê(¡­üÜß«).
  • gastric acid
    À§»ê(ß«)
  • gastric acid secretion
    À§(êÖ)(¾×(äû))»êºÐºñ(ß«ÝÂÝô).
  • gastric acid secretory studies
    À§»êºÐºñ °Ë»ç.
  • general acid
    ÀϹݻê(ìéÚõß«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • suck and snout reflex
    ÀԴٽñâ¹Ý»ç, »¡°íÇÓ ±â¹Ý»ç.
  • superficial (skin and mucous membrane
    Ç¥Àç(ÇǺΠ¹× Á¡¸·)¹Ý»ç.
  • superficial and deep parotid lymph nodes
    ¾è°í±íÀº±Í¹Ø»ù¸²ÇÁÀý, õ½ÉÀÌÇϼ±(ô¼ä¢ì¼?ÇØºÎ,À̺ñ
  • syndrome of neonatal fever, rash, and arthropathy
  • synovial bursae and sheaths
    À±È°ÁÖ¸Ó´Ï ¹× À±È°Áý
  • tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙ
  • tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
  • tentorial and subfacial herniation
    õ¸·ÀýÈçÅ»Ãâ ¹× ´ë³ú°âÇÏÅ»Ãâ
  • thoracostomy and underwater seal drainge
    Èä°­»ð°ü ¹× ¼öºÀ½Ä¹è¾×¹ý.
  • thyroidal protease and peptidase
    °©»ó¼±´Ü¹éºÐÇØÈ¿¼Ò(¡­Ó±ÛÜÝÂú°ý£áÈ).
  • time, dose and fractionation factor, TDF factor
    ½Ã°£¼±·®ºÐÇÒÀÎÀÚ
  • to and fro absorbent system
    ¿Õº¹Èí¼ö¹ý.
  • to and fro anesthesia apparatus
    ¿Õº¹½Ä¸¶Ãë±â(èÙÜÖãÒØ«ö­Ðï).
  • to and fro flow
    ÀüÈÄÀ¯µ¿.
  • to and fro method
    ¿Õº¹½Ä(èÙÜÖãÒ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • folinic acid
    Æú¸°»ê(ß«)
  • N5-formyltetrahydrofolic acid
    N5-Æ÷¸£¸» »ç¼ö¼Ò(ÞÌâ©áÈ)Æú»ê(ß«)
  • fulvic acid
    Ç®ºê»ê(ß«)
  • fumaric acid
    Ç»¸¶¸£»ê(ß«)
  • gamma aminobutyric acid
    °·¸¶ ¾Æ¹Ì³ëºêƼ¸£»ê(ß«)
  • general acid-base catalysis
    ÀϹÝ(ìéÚõ) »ê-¿°±â Ã˸Å(ß«-ç¤ÐñõºØÚ)ÀÛ¿ë
  • gibberellic acid
    Áö¹ö·¼¸°»ê(ß«)
  • glucoplastic amino acid
    ±Û·çÄÚ½º»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • glucuronic acid
    ±Û·çÅ¥·Ð»ê(ß«)
  • glucuronic acid oxidation pathway
    ±Û·çÅ¥·Ð»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • glutamic acid
    ±Û·çŽ»ê(ß«)
  • glutaric acid
    ±Û·çŸ¸£»ê(ß«)
  • glycaric acid
    ±Û¶óÀÌÄ«¸£»ê(ß«)
  • glycerophosphoric acid
    ±Û¸®¼¼·ÎÀλê(×òß«)
  • glycocholic acid
    ±Û¶óÀÌÄÚÄÝ»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
RDDP ribonucleic acid-dependent deoxynucleic acid polymerase
SFA saturated fatty acid; seminal fluid assay; serum folic acid; stimulated fibrinolytic activity; super...
SSA salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr...
TA alkaline tuberculin; arterial tension; axillary temperature; tactile afferent; Takayasu arteritis; t...
tRNA GLU transfer ribonucleic acid glutamic acid
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
Ca(2+) I(Ca) and
CD(3) CDCl(3) and
CSHA Canadian Study of Health and Aging
CALGB Cancer and Leukaemia Group B
CARDIAC Cardiovascular Disease and Alimentary Comparison
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • essential amino acid
    Çʼö ¾Æ¹Ì³ë»ê
    ´Ü¹éÁúÀÇ ±âº» ±¸¼º ´ÜÀ§. ´Ü¹éÁúÀº ü³»¿¡¼­ ¾Æ¹Ì³ë»êÀ¸·Î ºÐÇØµÇ°í ³ª¼­ Èí¼ö, ÀÌ¿ëµÈ´Ù. µû¶ó¼­ ´Ü¹éÁúÀÇ ¿µ¾ç°¡´Â ±× ¼Ó¿¡ ÇÔÀ¯µÇ´Â ¾Æ¹Ì³ë»êÀÇ Á¾·ù¿Í ¾ç¿¡ ÀÇÇÏ¿© Á¤ÇØÁø´Ù. ¾Æ¹Ì³ë»êÀº µ¿¹°ÀÇ Ã¼³»¿¡¼­ ´Ù¸¥ ¾Æ¹Ì³ë»êÀ¸·ÎºÎÅÍ ¸¸µé¾îÁö´Â °Í°ú, ü³»¿¡¼­´Â ÇÕ¼ºµÇÁö ¾Ê°í À½½ÄÀ¸·Î ¼·ÃëµÇ¾î¾ß ÇÏ´Â °ÍÀÌ ÀÖ´Ù. µû¶ó¼­ ¼·ÃëÇÏÁö ¾ÊÀ¸¸é ¿ÏÀüÇÑ ´Ü¹éÁúÀÌ µÇÁö ¾Ê´Â´Ù. ÀÌ·¸°Ô ü³»¿¡¼­ ÇÕ¼ºÇÒ ¼ö ¾ø´Â ¾Æ¹Ì³ë»êÀ» Çʼö ¾Æ¹Ì³ë»ê ¶Ç´Â ºÒ°¡°á ¾Æ¹Ì³ë»êÀ̶ó°í ÇÑ´Ù. Çʼö ¾Æ¹Ì³ë»êÀÇ Á¾·ù´Â µ¿¹°ÀÇ Á¾·ù³ª ¼ºÀå ½Ã±â¿¡ µû¶ó ´Ù¸£Áö¸¸, ¼ºÀÎÀÇ °æ¿ì¿¡´Â ´ÙÀ½ÀÇ 8Á¾ÀÌ´Ù. À̼ҷù½Å, ·ù½Å, ¸®½Å, Æä´Ò¾Ë¶ó´Ñ, ¸ÞƼ¿À´Ñ, Æ®·¹¿À´Ñ, Æ®¸³ÅäÆÇ, ¹ß¸°ÀÌ´Ù. ¾î¸°¾ÆÀÌÀÇ °æ¿ì¿¡´Â ¿©±â¿¡ È÷½ºÆ¼µòÀÌ ´õÇØÁø´Ù.
  • essential fatty acid
    Çʼö Áö¹æ»ê
    °íµîµ¿¹°ÀÇ ¼ºÀå ¶Ç´Â °Ç°­ »óÅÂÀÇ À¯Áö¸¦ À§ÇÏ¿© ü¿Ü·ÎºÎÅÍ ¼·ÃëÇØ¾ß ÇÒ Áö¹æ»ê. ºñŸ¹Î F¶ó°íµµ ÇÑ´Ù. Áö¹æÀº ü³»¿¡¼­ ÁÖ·Î ¿¡³ÊÁö¿øÀÌ µÇ¹Ç·Î ´Ù¸¥ °ÍÀ¸·ÎºÎÅÍ Ä®·Î¸®¸¦ ÃëÇϸé Áö¹æÀº ÇÊ¿ä¾øÁö ¾ÊÀº°¡ ÇÏ´Â Àǹ®ÀÌ »ý±ä´Ù. ±×·¯³ª À½½Ä ¼Ó¿¡ Áö¹æÀÌ ÀüÇô ¾øÀ¸¸é µ¿¹°ÀÇ ¼ºÀåÀÌ Á¤ÁöÇÏ°í Æ¯À¯ÇÑ ÇǺο°ÀÌ »ý±ä´Ù. ÀÌ Áõ¼¼´Â ¸®³î»ê, ¸®³î·»»ê, ¾Æ¶ó۵·»ê Áß ¾î´À °ÍÀ» ÇÔÀ¯ÇÏ´Â Áö¹æÀ» Åõ¿©Çϸé Ä¡À¯µÈ´Ù. ±×·¡¼­ À̵é Áö¹æÀ» ¾Æ¹Ì³ë»êÀÇ ¿¹¿¡ µû¶ó Çʼö Áö¹æ»êÀ̶ó°í ÇÑ´Ù. ÀÌ»óÀÇ ¼¼ °¡Áö Áö¹æ»ê Áß¿¡¼­ ¸®³î»êÀº ÀϹÝÀûÀÎ À¯Áö¿¡ ³Î¸® ÇÔÀ¯µÇ¾î ÀÖÀ¸¹Ç·Î, º¸ÅëÀÇ Áö¹æÀ» ¼·ÃëÇϸé Áö¹æ»êÀÌ °áÇÌÇÏ´Â ÀÏÀº ¾ø´Ù.
  • ethacrynic acid
    ¿¡Å¸Å©¸°»ê
  • ethylene-diamin tetra-acetic acid
    ¿¡Æ¿·»µð¾Æ¹Î »ç-¾Æ¼¼Æ®»ê
    ¹é»öÀÇ ºÐ¸»·Î Á߱ݼÓ. ¾ËÄ®¸®Åä ±Ý¼Ó µî°ú È­ÇÕÇÏ¿© Àß ³ì´Â ¸Å¿ì ¾ÈÁ¤µÈ Ű·¹ÀÌÆ® È­ÇÕ¹°À» ¸¸µé°í, ¹æ»ç¼º ¿ø¼ÒÀÇ Å»¿À¿°. ¹°ÀÇ °æµµ ºñ»ö ºÐ¼®. ±Ý¼ÓÀÇ ¿ë·® ºÐ¼® µî¿¡ »ç¿ëµÇ¸ç, ÃÖ±Ù¿¡´Â Ç÷¾×À» ÀúÀåÇϴµ¥ ÷»çÇϸé Ç×ÀÀ°í¼º°ú º¸Á¸ ±â°£ÀÇ ¿¬ÀåÀ» °¡´ÉÄÉ ÇÑ´Ù´Â °ÍÀÌ ÆÇ¸íµÇ¾ú´Ù.
  • fatty acid cyclooxygenase
    Áö¹æ»ê »çÀÌŬ·Î¿Á½ÃÁö³×À̽º
  • folic acid antagonist
    ¿±»ê ±æÇ×Á¦
  • folic acid deficiency anemia
    ¿±»ê °áÆð¼º ºóÇ÷
  • formic acid
    Æ÷¸§»ê, °³¹Ì»ê, ÀÇ»ê
  • formiminoglutamic acid
    Æ÷¸£¹Ì¹Ì³ë±Û·çŸ¹Í »ê
    ±Û·çŸ¹Î»êÀÌ È÷½ºÆ¼Æ¾À¸·Î ºÐÇØµÇ´Â °ú Á¤ÀÇ Áß°£ »ê¹°ÀÌ´Ù.
  • free acid
    À¯¸® »ê
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • fumaric acid
    Ǫ¸¶¸£ »ê
    ºÒÆ÷È­ ÀÌ¿°±â»ê. Æ®¶óÀÌ Ä«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£Ã¼.
  • humic acid
    È޹λê
  • humus acid
    ºÎ½Ä »ê
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê
    ÁÖÁ¶¹° ¼¼Ã´ ¿ë¾×À¸·Î »ç¿ëµÇ´Â »ê ¿ë¾×.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
hemic and lymphatic diseases Haematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., erythrocyte aggregation, intravascular) and chemical components (e.g., blood protein disorders); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.
(12 Dec 1998)
hepatitis d, e, f, and g Lesser known (than hepatitis a, b, and c), the most significant of these seems to be type d, or the delta agent, which only causes disease in the presence of the hepatitis b virus.
(12 Dec 1998)
hereditary deafness and nephropathy <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon.
Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision.
Inheritance: sex-linked autosomal dominant.
Incidence: 1 in 50,000.
Origin: Gr. Pathos = disease
(27 Sep 1997)
prostheses and implants Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. Implants, experimental is available for those used experimentally.
(12 Dec 1998)
prothrombin and proconvertin test A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs.
Synonym: P and P test.
(05 Mar 2000)
schizophrenia and disorders with psychotic features Marked disorders of thought (delusions, hallucinations, or other thought disorder accompanied by disordered affect or behaviour), and deterioration from a previous level of functioning.
(12 Dec 1998)
protoveratrine A and B A mixture of two alkaloids isolated from Veratrum album; they exert their main effect upon the cardiovascular system through the carotid sinus receptors and vagal sensory endings in the heart; they cause vasodilation and are thought to bring about a redistribution to all vascular beds and thus to induce a fall in blood pressure; used in certain forms of hypertension; the maleates have the same actions.
(05 Mar 2000)
psychological phenomena and processes Mechanisms and underlying psychological principles of mental processes and their applications.
(12 Dec 1998)
hoof-and-mouth disease An obsolete term for foot-and-mouth disease.
(05 Mar 2000)
hormones, hormone substitutes, and hormone antagonists A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.
(12 Dec 1998)
sensitivity and specificity Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person.
(12 Dec 1998)
hospital design and construction The architecture, functional design, and construction of hospitals.
(12 Dec 1998)
Hunter and Driffield curve Sensitometric curve of radiographic film, a plot of the film density versus the logarithm of the relative exposure.
Synonym: H and D curve, Hunter and Driffield curve.
(05 Mar 2000)
sexual and gender disorders Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders.
(12 Dec 1998)
sheath of Key and Retzius <anatomy> The delicate bands of connective tissue among nerve fibres.
Origin: NL, fr. Gr. Within + a sinew, nerve.
Source: Websters Dictionary
(01 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • gin and tonic
    ÁøÅä´Ð
  • hammer and sickle
    (ÇØ¸Ó¿Í ³´À¸·Î µÈ)¼Ò·Ã ±¹±â
  • haves and havenots
    ÇÙ º¸À¯±¹°ú ºñº¸À¯±¹;(ÀϹÝÀûÀ¸·Î)°¡Áø ÀÚ(³ª¶ó)¿Í °®Áö ¸øÇÑ ÀÚ(³ª¶ó)
  • hen and chickens
    ±äº´²É(²ÜÇ®°ú);µ¢±¼°í¾Æ´ë¼ö¿°(±¤´ë³ª¹°°ú)
  • hole and corner
    ºñ¹ÐÀÇ;Â÷ÂúÀº
  • hoof and mouth disease
    =FOOT AND MOUTH DISEASE
  • hunt and peck
    ŸÀڱ⸦ Á¦¸Ú´ë·Î Ä¡´Â ÀÏ
  • in and in
    µ¿Á¾ ±³¹èÀÇ(·Î)
  • in and out
    (Áõ±ÇµîÀ» ´Ü±â·Î)¸Å¸ÅÇÏ´Â;(¹Ì¼Ó)µéÂß³¯ÂßÀÇ
  • in and outer
    (¹Ì¼Ó)(ÄÁµð¼ÇÀÌ)°í¸£Áö ¸øÇÑ ¼±¼ö(¿¬¿¹ÀÎ)
  • lares and penates
    Áý¾ÈÀÇ ¼öÈ£½Å;ÅÍÁÖ;°¡º¸;°¡Àç
  • make-and-break
    °³Æó½ÄÀÇ
  • mild and bitter
    ´Ü¸À ¾´¸ÀÀÌ ¹Ý¹ÝÀÎ ¸ÆÁÖ
  • milk and water
    ±èºüÁø;¸ß¾ø´Â;¸÷½Ã °¨»óÀûÀÎ
  • mix and match
    ±ÕÇüÀÌ ¸ÂÁö ¾Ê´Â °Í ³¢¸®ÀÇ Â¦Áö¿ò
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á